Updated findings from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study (NCT04221945) show the survival advantages of ...

Keytruda contains the active ingredient pembrolizumab. (An active ingredient is what makes a drug work.) Keytruda is a biologic medication. A biologic is made from parts of living organisms.

Carter received the second such drug, pembrolizumab, which was authorized ... "The best favor you can do for a famous patient is forget that they’re famous. The cancer doesn’t care," he ...

It is a treatment that does not kill cancer cells itself but instead stimulates the body's immune system to attack them. Pembrolizumab ... But it may not work for everyone. In people with advanced ...

As a result, NICE has said that the results of the KEYNOTE-048 clinical trial, which grouped all forms of head and neck cancer together irrespective of their location and used the three-drug cocktail ...

I asked whether he worries that the work could lead to editing embryos for traits that parents prize. He flicked his hand in exasperation. “I don’t do gene editing. I don’t do manipulation ...

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way that ovarian cancer tumors manipulate their ...

“We know [immunotherapy] can work in untreated or previously treated but ... in a review of the topic at the recent World Conference on Lung Cancer. But how does a large molecule, like pembrolizumab, ...

Should you invest in Bicara Therapeutics Inc? Click for more on BCAX's promising cancer treatment, but proceed with caution ...

What if one treatment could do the work of two inhibitors ... administering chemotherapy with a PD-1 targeting inhibitor called pembrolizumab can achieve more durable responses than chemotherapy ...

With a clearly defined regulatory path forward for Nana-val, we believe this will allow us to be efficient while we work toward the possible submission ... valganciclovir, and pembrolizumab for ...